Here's why Goldman Sachs upgraded IDP Education shares to 'buy'  

Goldman Sachs has recommended growth company IDP Education as a Buy with a target price of $25.40.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IDP Education Limited (ASX: IEL) share price was top performer on the S&P/ASX 200 (INDEXASX: XJO) last week, climbing a whopping 36.4% and reaching a record high. IDP Education shares have retreated in morning trade and are currently trading 4.04% lower at $22.55.

IDP Education provides international student placement services and English language testing services. It also runs a string of English language schools in South East Asia and organises educational events and conferences globally. 

The recommendation change

IDP's share price fell 18% between 20 January and 3 February on fears of the impact of the coronavirus. It later surged by 28% in one day on 12 February after an earnings report showing increases against previous calendar period (pcp) of 49% in earnings before interest and tax. 

The company's earnings performance was due to improvements in revenue generation across all business lines and improvements in margin. IDP's core business of student placement saw a 30% volume growth principally from the UK and Canada.

Key to its profitability and revenue growth has been the company's rapid roll out of its computer-delivered International English Language Testing System (IELTS) over 47 countries. In addition, 37 venues were opened during FY20 H1.

Goldman Sachs' recommendation upgrade is based largely on a judgement that the current coronavirus crisis will not pose a "structural" impact on IDP's performance. The company has proven that it can manage the impact of coronavirus thus far, due to the geographical diversity of its operating locations. 

Goldman Sachs estimates that IDP's exposure to China is approximately 10.9% of revenue on a full-year FY20 basis. This is revenue the company is already replacing via revenue streams and in other markets. 

The value proposition

IDP is one of the true recent growth stories of the ASX. Over the past 4 years, it has a compound annual growth rate (CAGR) of 14.2% in sales, 13.7% in earnings per share and 14.8% in cash flow. 

With a share price (CAGR) of 52.4%, $10,000 invested in IDP Education on 1 January 2016 would have been worth $53,909 on 1 January 2020.

IDP has demonstrated a very strong capability for turning capital into increased revenues with a return on capital expended (ROCE) of 63% in FY19 and 75% in FY18.

The company's business model means that expended capital results in additional teachers, marketing and sales resources, and resources to deliver training and student placements, which are all revenue generating units in some form or other. IDP also owns one-third of IELTS, providing an additional revenue stream.

The one issue with the IDP stock is the share price. It is presently trading at a price-to-earnings (P/E) ratio of 71.5. Historically, its P/E ratio has always been high with the FY19 average sitting at 46. The market and Goldman Sachs have clearly factored in future growth potential and expect the company to have a long runway ahead of it.  

Foolish takeaway

Goldman Sachs' change in recommendation was anchored to the growth revealed by IDP in the company's H1 earnings report, which also highlighted that the impact of the coronavirus outbreak has been negligible thus far. 

IDP is a very well managed growth prospect. The size of its market and the company's management have turned it into a capital compounding machine, underscored by its very strong ROCE performance. It is likely to see a full-year FY20 impact from the coronavirus, but at this stage this will be a short-term effect.

At an earnings multiple of approximately 77, investors will need to ask whether they agree this company is well positioned to continue its growth trajectory for years to come.

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »